Ya Zeng

497 total citations
25 papers, 342 citations indexed

About

Ya Zeng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ya Zeng has authored 25 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Ya Zeng's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Mechanisms and Therapy (4 papers). Ya Zeng is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Mechanisms and Therapy (4 papers). Ya Zeng collaborates with scholars based in China. Ya Zeng's co-authors include Zehua Wang, Jing Cai, Zhengfei Zhu, Li Chu, Linjuan Xu, Yue Zhou, Jianjiao Ni, Xi Yang, Yang Zhao and Xiao Chu and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer and Cancer Letters.

In The Last Decade

Ya Zeng

23 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ya Zeng China	11	156	147	128	64	64	25	342
Nicole Liscia Italy	7	112 0.7×	226 1.5×	131 1.0×	73 1.1×	104 1.6×	29	374
Carminia M. Della Corte Italy	7	103 0.7×	139 0.9×	129 1.0×	37 0.6×	71 1.1×	14	323
Efimia Boutsikou Greece	6	158 1.0×	155 1.1×	112 0.9×	54 0.8×	65 1.0×	12	351
Vincenzo De Falco Italy	12	88 0.6×	244 1.7×	144 1.1×	57 0.9×	90 1.4×	38	396
Santiago Ponce-Aix Spain	11	233 1.5×	199 1.4×	159 1.2×	34 0.5×	59 0.9×	17	425
Laia Vilà Spain	8	86 0.6×	168 1.1×	183 1.4×	38 0.6×	49 0.8×	20	325
Ruozheng Wang China	12	84 0.5×	157 1.1×	141 1.1×	111 1.7×	97 1.5×	47	412
Sarah E. Fenton United States	11	91 0.6×	159 1.1×	156 1.2×	88 1.4×	31 0.5×	27	388
Arsène‐Bienvenu Loembé United Kingdom	9	100 0.6×	196 1.3×	168 1.3×	42 0.7×	33 0.5×	15	377
Ludimila Cavalcante United States	12	78 0.5×	238 1.6×	148 1.2×	82 1.3×	60 0.9×	54	423

Countries citing papers authored by Ya Zeng

Since Specialization

Citations

This map shows the geographic impact of Ya Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya Zeng more than expected).

Fields of papers citing papers by Ya Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya Zeng. The network helps show where Ya Zeng may publish in the future.

Co-authorship network of co-authors of Ya Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ya Zeng. A scholar is included among the top collaborators of Ya Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya Zeng. Ya Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Lunxi, Liang Xiao, Ya Zeng, Fen Wang, & Xin Yu. (2025). Establishment and validation of a nomogram for predicting esophagogastric variceal bleeding in patients with liver cirrhosis. World Journal of Gastroenterology. 31(9). 102714–102714. 3 indexed citations

Zeng, Ya, Xi Su, Jingyi Jia, et al.. (2024). Propensity-matched study on locally advanced esophageal cancer: surgery versus post-operative radiotherapy. Radiation Oncology. 19(1). 130–130. 1 indexed citations

Zeng, Ya, et al.. (2024). The role of radiotherapy in extensive-stage small cell lung cancer: insights from treatment failure patterns in the era of immunotherapy. BMC Cancer. 24(1). 1534–1534.

Xu, Xin, et al.. (2024). The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study. Clinical and Translational Radiation Oncology. 48. 100818–100818.

Gao, Lingling, Jing Cai, Man Xiao, et al.. (2023). Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. Journal of Ovarian Research. 16(1). 27–27. 6 indexed citations

Li, Wenhan, Pan Liu, Jing Zhao, et al.. (2022). Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer. Cancer Letters. 529. 168–179. 65 indexed citations

Zeng, Ya, Tiantian Guo, Yue Zhou, et al.. (2022). Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters. BMC Cancer. 22(1). 198–198. 9 indexed citations

Long, Yan, et al.. (2022). Endoplasmic reticulum stress contributed to inflammatory bowel disease by activating p38 MAPK pathway. European Journal of Histochemistry. 66(2). 17 indexed citations

Yu, Fan, Jianjiao Ni, Yue Zhou, et al.. (2021). Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer With Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 111(3). 804–815. 28 indexed citations

10.

Li, Guoqing, Xiaohan Xu, Jing Cai, et al.. (2021). FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer. Cancer Cell International. 21(1). 568–568. 22 indexed citations

11.

Zhao, Yang, Shuyan Li, Xi Yang, et al.. (2021). Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis. International Journal of Cancer. 150(8). 1318–1328. 30 indexed citations

12.

Zhou, Yue, Fan Yu, Yang Zhao, et al.. (2020). A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player. Translational Lung Cancer Research. 9(6). 2479–2493. 10 indexed citations

13.

Zeng, Ya, Jianjiao Ni, Fan Yu, et al.. (2020). The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease. Radiation Oncology. 15(1). 207–207. 26 indexed citations

14.

Zhou, Yue, Bo Wang, Fan Yu, et al.. (2020). Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors. Lung Cancer. 150. 178–185. 22 indexed citations

15.

Zhao, Lei, Yang Zhao, Ya Zeng, et al.. (2020). Effective Radiotherapy in Tracheobronchial Adenoid Cystic Carcinoma With Positive Surgical Margin. The Annals of Thoracic Surgery. 112(5). 1585–1592. 7 indexed citations

16.

Zeng, Ya, Wen Yu, Qi Liu, et al.. (2019). Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy. World Journal of Gastrointestinal Oncology. 11(12). 1172–1181. 7 indexed citations

17.

Xie, Yuanhong, et al.. (2018). Pim-1 inhibitor attenuates trinitrobenzene sulphonic acid induced colitis in the mice. Clinics and Research in Hepatology and Gastroenterology. 42(4). 382–386. 5 indexed citations

18.

Xie, Yuanhong, et al.. (2017). Pim-1 kinase regulates CD4+T cell differentiation. Biomedical Research-tokyo. 28(19). 8267–8270. 1 indexed citations

19.

Jiang, Fei, Rongquan Wang, Xiaozhong Guo, et al.. (2017). Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm‐like pain: A randomized, double‐blinded, multicenter Phase III trial. Journal of Digestive Diseases. 18(8). 453–460. 8 indexed citations

20.

Zhao, Yan, et al.. (2012). Inhibition of Pim-1 Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice. Digestive Diseases and Sciences. 57(7). 1822–1831. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact